Oramed Pharmaceuticals, Inc. (ORMP)
4.74
+0.07
(+1.50%)
USD |
NASDAQ |
Sep 18, 16:00
4.74
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Cash from Operations (Quarterly) : -0.2799M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2799M |
| March 31, 2026 | -2.915M |
| December 31, 2025 | -0.6243M |
| September 30, 2025 | -1.991M |
| June 30, 2025 | -3.564M |
| March 31, 2025 | -3.519M |
| December 31, 2024 | -1.93M |
| September 30, 2024 | -7.071M |
| June 30, 2024 | 2.071M |
| March 31, 2024 | -1.476M |
| December 31, 2023 | -1.337M |
| September 30, 2023 | -0.5456M |
| June 30, 2023 | -2.502M |
| March 31, 2023 | -5.549M |
| December 31, 2022 | -7.622M |
| September 30, 2022 | -2.133M |
| June 30, 2022 | -8.077M |
| March 31, 2022 | -9.802M |
| August 31, 2021 | -6.278M |
| May 31, 2021 | -5.581M |
| February 28, 2021 | -3.461M |
| November 30, 2020 | -6.152M |
| August 31, 2020 | -2.817M |
| May 31, 2020 | -3.163M |
| February 29, 2020 | -3.679M |
| Date | Value |
|---|---|
| November 30, 2019 | -2.996M |
| August 31, 2019 | -3.411M |
| May 31, 2019 | -3.811M |
| February 28, 2019 | -1.856M |
| November 30, 2018 | -4.131M |
| August 31, 2018 | -4.648M |
| May 31, 2018 | -3.805M |
| February 28, 2018 | -3.476M |
| November 30, 2017 | -2.728M |
| August 31, 2017 | -2.048M |
| May 31, 2017 | -2.356M |
| February 28, 2017 | -2.925M |
| November 30, 2016 | 1.498M |
| August 31, 2016 | 6.803M |
| May 31, 2016 | -2.225M |
| February 29, 2016 | 2.324M |
| November 30, 2015 | -2.247M |
| August 31, 2015 | -1.029M |
| May 31, 2015 | -0.914M |
| February 28, 2015 | -1.604M |
| November 30, 2014 | -1.399M |
| August 31, 2014 | -0.8019M |
| May 31, 2014 | -1.035M |
| February 28, 2014 | -1.482M |
| November 30, 2013 | -0.7487M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly & Co. | 10.69B |
| Pfizer Inc. | 835.00M |
| Liquidia Corp. | 80.24M |
| Scilex Holding Co. | -6.723M |
| BioAge Labs, Inc. | -19.26M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 3.920M |
| Cash from Financing (Quarterly) | -2.265M |
| Free Cash Flow | -5.820M |
| Free Cash Flow Per Share (Quarterly) | -0.0066 |
| Free Cash Flow to Equity (Quarterly) | -0.2541M |
| Free Cash Flow to Firm (Quarterly) | -0.2821M |
| Free Cash Flow Yield | -2.93% |